April 3, 2017
Once-weekly semaglutide lowers blood glucose and weight with type 2 diabetes patients
Novo Nordisk said Monday that once-weekly semaglutide demonstrated consistent blood glucose reductions and weight loss regardless of background oral antidiabetic treatment.